Brief: Diamyd Medical Q1 Net Loss Widens To SEK 48.8 Mln
Jan 28 (Reuters) - Diamyd Medical AB DMYDb.ST: Q1 NET SALES MSEK 0.2 (0.0) Q1 CASH FLOW FROM OPERATING ACTIVITIES MSEK -43.7 (-41.8) Q1 NET RESULT MSEK -48.8 (-36.2) PLANS MARCH 2026 EARLY-READOUT OF PHASE 3 TRIAL Source text: ID:nWkrcc1PbX Further company coverage: [DMYDb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))